论文部分内容阅读
目的评估转移性肾细胞癌接受酪氨酸激酶抑制剂(TKI)治疗两期后,肿瘤CT质地参数的变化是否与肿瘤治疗后变化有关。材料与方法此回顾性分析免除专业审查委员会的批准。39例转移性肾细胞癌病人TKI治疗前后均接受对比剂增强CT检查,测量其CT质地参数。共分析87处
Objective To evaluate whether changes in the CT texture parameters of metastatic renal cell carcinoma (TCC) after treatment with TKI are related to the changes after treatment. Materials and Methods This retrospective analysis exempts the Professional Review Board’s approval. 39 patients with metastatic renal cell carcinoma before and after treatment of TKI patients underwent contrast-enhanced CT examination of CT texture parameters. A total of 87 analysis